What is the Return on Assets (ROA) of Ergomed this year?
The Return on Assets (ROA) of Ergomed is 0.12 undefined this year.
Ergomed ROA 2024
Ergomed ROA
0.12
Ticker
ERGO.L
ISIN
GB00BN7ZCY67
WKN
A117XM
In 2024, Ergomed's return on assets (ROA) was 0.12, a -3.14% increase from the 0.12 ROA in the previous year.
Ergomed Aktienanalyse
What does Ergomed do?
Ergomed PLC is a company specialized in clinical research, based in the UK since 1997. It specializes in supporting biotech and pharmaceutical companies in conducting clinical phase studies and post-marketing surveillance. Ergomed is listed on the London Stock Exchange and has offices in Europe and the USA. The company was originally founded as Ergomed Clinical Research Limited by physician Miroslav Reljanovic, who recognized the lack of resources for small biotech companies to conduct their own clinical studies. Ergomed offers a range of services tailored to the needs of biotech and pharmaceutical companies, including clinical research services, medical information and pharmacovigilance services, and regulatory affairs. It also provides venture capital investments for selected biotech companies. Ergomed offers comprehensive clinical research services, including study planning, trial management, and study monitoring. It also has expertise in data management and statistics to ensure accurate results. The company provides medical information to inform patients and healthcare professionals and offers support for drug monitoring during and after approval. Ergomed also supports companies in submitting regulatory applications and addressing regulatory questions. It has extensive experience working with national, European, and global regulatory authorities to ensure drug approval and compliance. Ergomed does not offer its own products but provides services to biotech and pharmaceutical companies. It collaborates with various companies to conduct clinical trials and develop drugs. In conclusion, Ergomed is a specialized company in clinical research that offers a wide range of services to biotech and pharmaceutical companies. It specializes in supporting them in conducting clinical phase studies and post-marketing surveillance. Ergomed has extensive experience working with regulatory authorities at national, European, and global levels to ensure drug approval and compliance. Ergomed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Ergomed's Return on Assets (ROA)
Ergomed's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Ergomed's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Ergomed's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Ergomed’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Ergomed stock
What was the ROA of Ergomed compared to the previous year?
The ROA of Ergomed has increased by -3.14% compared to the previous year.
What consequences do high ROA have for investors of Ergomed?
A high ROA is advantageous for investors of Ergomed, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Ergomed?
A low ROA can be unfavorable for investors of Ergomed as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Ergomed affect the company?
An increase in ROA of Ergomed can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Ergomed impact the company?
A reduction in the ROA of Ergomed can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Ergomed?
Some factors that can influence the ROA of Ergomed include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Ergomed important for investors?
The ROA of Ergomed is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Ergomed take to improve ROA?
To improve ROA, Ergomed can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Ergomed pay?
Over the past 12 months, Ergomed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ergomed is expected to pay a dividend of 0 GBP.
What is the dividend yield of Ergomed?
The current dividend yield of Ergomed is .
When does Ergomed pay dividends?
Ergomed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ergomed?
Ergomed paid dividends every year for the past 0 years.
What is the dividend of Ergomed?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ergomed located?
Ergomed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ergomed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ergomed from 9/13/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.
When did Ergomed pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Ergomed in the year 2023?
In the year 2023, Ergomed distributed 0 GBP as dividends.
In which currency does Ergomed pay out the dividend?
The dividends of Ergomed are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ergomed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ergomed
Our stock analysis for Ergomed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ergomed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
